Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
detroit blog main
detroit top stories
fail
2
×
indiana blog main
indiana top stories
life sciences
nash
2
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
study
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2025
acc
acquisition
activist investor
ad-comm
aducanumab
affimed
akcea therapeutics
allogene therapeutics
What
bio
roundup
adu
allogene
approved
beats
bids
biogen
cancer
complicated
crispr
depression
dire
diversity
drug
good
group
heart
help
hot
immunotherapy
investors
ipo
juno
medical
million
nearly
need
new
news
people
postpartum
relief
remains
sage
shares
snapped
therapeutics
ticket
utero
Language
Current search:
fail
×
nash
×
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
